Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v8-EN
Language English English
Date Updated 2020-02-14 2020-02-13
Drug Identification Number 02456958 02456958
Brand name HEPARIN SODIUM INJECTION USP HEPARIN SODIUM INJECTION USP
Common or Proper name Heparin Sodium Injection Heparin Sodium Injection
Company Name STERINOVA INC STERINOVA INC
Ingredients HEPARIN SODIUM HEPARIN SODIUM
Strength(s) 5000UNIT 5000UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10 10
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-01-29 2020-01-29
Actual start date
Estimated end date 2020-02-13 2020-02-13
Actual end date 2020-02-13 2020-02-13
Shortage status Resolved Actual shortage
Company comments Shortage resolved. Product is being distributed to wholesalers on Feb 13th, 2020. Shortage resolved. Product is being distributed to wholesalers on Feb 13th, 2020.
Health Canada comments